openPR Logo
Press release

Investigation announced for Long-Term Investors in CytoDyn Inc. (OTC: CYDY)

07-16-2021 09:37 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in CytoDyn Inc. (OTC: CYDY) shares.

An investigation on behalf of current long term investors in CytoDyn Inc. (OTC: CYDY) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of CytoDyn Inc.

Investors who are current long term investors in CytoDyn Inc. (OTC: CYDY) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in OTC: CYDY stocks follows a lawsuit filed against CytoDyn Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in OTC: CYDY stocks, concerns whether certain CytoDyn directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Western District of Washington the plaintiff alleges that the defendants made materially false and/or misleading statements, and failed to disclose that while CytoDyn's stock price was sufficiently pumped with the COVID-19 cure hype, long-term shareholders, including CEO Nader Z. Pourhassan and CFO Michael Mulholland, dumped millions of shares, that CytoDyn engaged in a wrongful scheme with its lender, Iliad Research and Trading L.P. ("Iliad"), and its principal John Fife ("Fife"), whereby Iliad and other Fife entities operated as an unregistered securities dealer for CytoDyn, and that Iliad obtained a convertible promissory note from CytoDyn and converted the note into newly issued shares of CytoDyn and sold those shares into the public market at a profit, in violation of the dealer registration requirements of the federal securities laws.

Those who purchased shares of CytoDyn Inc. (OTC: CYDY) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in CytoDyn Inc. (OTC: CYDY) here

News-ID: 2330785 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for CytoDyn

Human Immunodeficiency Virus Type-1 (HIV-1) Therapeutic Pipeline Analysis | Insi …
As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Human Immunodeficiency Virus Type-1 (HIV-1) therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Human Immunodeficiency Virus Type-1 (HIV-1) Pipeline Insight, 2022" report
COVID-19 Therapeutics Market Outlook 2021: The Strong Pipeline with New Product …
The newly released report entitled "Global COVID-19 Therapeutics Market– By Trends, Clinical Trial/Pipeline Analysis, Industry Competition Analysis, Revenue and Forecast Till 2030." of InsightAce Analytic Pvt. Ltd. features in-depth analysis and an extensive study on the market, exploring its significant factors. Based on drug class market has been segmented into Antiviral, Monoclonal Antibodies, Anticoagulant, Glucocorticoid, Nitric oxide and Other Emerging Drug Class. For More Information @ https://www.insightaceanalytic.com/report/global-covid-19-therapeutics-market/1184 According to the latest market
The COVID-19 Therapeutics Market Research Report 2021| Key Player: Celltrion Hea …
InsightAce Analytic Pvt. Ltd. announces the market assessment report on “Global COVID-19 Therapeutics Market– By Trends, Industry Competition Analysis, Clinical Trial/Pipeline Analysis, Revenue and Forecast Till 2030.” Request for Sample Pages: https://www.insightaceanalytic.com/report/global-covid-19-therapeutics-market/1184 According to the latest market intelligence report by InsightAce Analytic, the global COVID-19 therapeutics market size is valued at US$ 5.26 Billion in 2020, and it is expected to reach US$ 25.6 Billion in 2030, recording a promising CAGR of
Deadline on May 17th coming up in Lawsuit for Investors in CytoDyn Inc. (OTC: CY …
A deadline is coming up on May 17, 2021 in the lawsuit filed for certain investors of CytoDyn Inc. (OTC: CYDY) over alleged securities laws violations by CytoDyn Inc. Investors who purchased shares of CytoDyn Inc. (OTC: CYDY) have certain options and there are strict and short deadlines running. Deadline: May 17, 2021. OTC: CYDY stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Lawsuit filed for Investors in shares of CytoDyn Inc. (OTC: CYDY)
An investor, who purchased shares of CytoDyn Inc. (OTC: CYDY), filed a lawsuit over alleged violations of Federal Securities Laws by CytoDyn Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of CytoDyn Inc. (OTC: CYDY) have certain options and for certain investors are short and strict deadlines running. Deadline: May 17, 2021. OTC: CYDY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Global HIV Drugs Market Analysis of Emerging Key Vendors Such as Gilead Sciences …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on “Global HIV Drugs Market Assessment – Revenue (US$ Mn) Forecast Till 2028” Request for Sample Pages: https://www.insightaceanalytic.com/report-details/global-hiv-drugs-market-assessment/ According to the latest research by InsightAce Analytic, the global HIV drugs market was valued at US$ XX Mn in 2020 and it is expected to reach US$ XX million in 2028, at a promising CAGR of XX% from 2020 to